This page has been archived on the Web
Information identified as archived is provided for reference, research or recordkeeping purposes. It is not subject to the Government of Canada Web Standards and has not been altered or updated since it was archived. Please contact us to request a format other than those available.
Teva-Lorazepam 1 mg (2017-02-09)
- Starting date:
- February 9, 2017
- Posting date:
- February 22, 2017
- Type of communication:
- Drug Recall
- Subcategory:
- Drugs
- Hazard classification:
- Type III
- Source of recall:
- Health Canada
- Issue:
- Product Safety
- Audience:
- General Public, Healthcare Professionals, Hospitals
- Identification number:
- RA-62296
Reason
Out of specification result for Organic Impurity - USP Related Compound C during stability testing.
Depth of distribution
Alberta, British Columbia, Manitoba, New Brunswick, Newfoundland, Nova Scotia, Ontario, Quebec and Saskatchewan.
Affected products
Teva-Lorazepam 1 mg
DIN, NPN, DIN-HIM
DIN 00637742
Dosage form
Tablet
Strength
1 mg
Lot or serial number
35342323E
35342324A
35343041E
Companies
- Recalling Firm
-
Teva Canada Ltd.
30 Novopharm Court
Toronto
M1B 2K9
Ontario
CANADA
- Marketing Authorization Holder
-
Teva Canada Ltd.
30 Novopharm Court
Toronto
M1B 2K9
Ontario
CANADA